4C PHARMA SOLUTIONS
LIVE

Serial Number

88232337

Owner

4C Pharma Solutions LLC

Attorney

ESTEBAN O'FARRELL

First Use Date

Sep 8, 2018

Filing Date

Dec 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

4C PHARMA SOLUTIONS Trademark

Serial Number: 88232337 • Registration: 5849323

4C PHARMA SOLUTIONS is a trademark filed by 4C Pharma Solutions LLC on December 17, 2018. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

4C Pharma Solutions LLC (3 trademarks)

Suite 111
Piscataway, NJ 08854

Entity Type: 16

Trademark Details

Filing Date

December 17, 2018

Registration Date

September 3, 2019

First Use Anywhere

September 8, 2018

First Use in Commerce

September 8, 2018

Published for Opposition

June 18, 2019

Goods & Services

Providing medical information in the field of pharmacovigilance and clinical trials

Training services in the field of pharmacovigilance and regulatory compliance

Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics

Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services

Technical writing for others; technical writing in the field of medical writing; searching and retrieving information, sites, and other resources available on computer networks for others; consulting services for others in the field of design, planning, and implementation project management of clinical trials and pharmacovigilance; installation and maintenance of pharmacovigilance computer software; tracking and monitoring of safety and/or efficacy for drugs, devices, drug/device combinations, biologics, biosimilars, cosmetics, nutraceuticals or consumer products for others for pharmacovigilance purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 16, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 16, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 15, 2026 APRE
TEAS SECTION 8 RECEIVED
Mar 2, 2026 ES8R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2026 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 3, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 15, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 10, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2019 CNEA
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
May 3, 2019 ZZAX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2019 CNEA
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
May 3, 2019 ZZAX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2019 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 2, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 23, 2019 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 11, 2019 PREV
ASSIGNED TO LIE
Apr 10, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 18, 2019 CNEA
ASSIGNED TO EXAMINER
Mar 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2019 NWOS
NEW APPLICATION ENTERED
Dec 20, 2018 NWAP